Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors inside the central nervous system, conolidine modulates alternate molecular targets. A Science Innovations study identified that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide avail... https://zanejgzjs.sharebyblog.com/37638200/the-ultimate-guide-to-alternative-natural-pain-relief-to-replace-traditional-painkillers